Goldiam International Receives Export Order Valued At ₹50 Crore

Market snapshot: Goldiam International Limited has bagged an export order worth ₹50 crore from international USA clients for manufacturing and exporting lab-grown diamond-studded gold jewellery. The entire order is scheduled to be executed on or before November 30, 2026, boosting the company's near-term revenue visibility.

Data Snapshot

• The fresh export order is valued at ₹50 crore.
• Goldiam's B2B export order book stood at ₹225 crore as of June 30, 2026.
• Consolidated net profit for Q1 FY27 reached ₹73.97 crore.
• The company's cash and cash equivalents stood at ₹456.67 crore as of June 30, 2026.

What's Changed

• Order Book Pipeline: The new ₹50 crore order expands Goldiam's robust order book pipeline, which had previously reached ₹225 crore as of June 30, 2026.
• Earnings Growth: Q1 FY27 consolidated net profit surged 120% YoY to ₹73.97 crore, up from ₹33.62 crore in Q1 FY26.

Key Takeaways

• Goldiam International has bagged a ₹50 crore B2B export order for lab-grown diamond-studded gold jewellery from US-based clients.
• The order has a strict near-term timeline, with execution scheduled on or before November 30, 2026, ensuring high revenue visibility for Q2 and Q3 FY27.
• Lab-grown diamond jewellery remains the core growth engine for Goldiam, accounting for 90.7% of its total export sales mix in Q1 FY27.
• This order comes on the heels of robust quarterly results, with the company's order book already sitting at ₹225 crore as of June 30, 2026.

SAHI Perspective

Goldiam’s strategic pivot towards lab-grown diamonds (LGD) is yielding exceptional results. By managing the entire value chain from CVD diamond growing to retail, Goldiam has insulated itself from traditional diamond commodity price volatility. This new ₹50 crore order, which must be executed in under 3.5 months, indicates strong, recurring demand from key US retail partners. Given the higher EBITDA margins associated with captive lab-grown jewellery (EBITDA grew 120% in Q1 FY27), this order is expected to support the company's upgraded margin profile in the coming quarters.

Market Implications

The gems and jewellery export sector has faced headwinds due to US tariffs and geopolitical tensions. However, Goldiam's performance demonstrates a clear decoupling, driven by the massive consumer shift towards sustainable luxury (LGDs) in the US. Successful execution of short-cycle export orders like this one will likely boost investor confidence in Goldiam's execution capabilities and its unique dual-casting model (casting in the US to mitigate tariff risks).

Trading Signals

Market Bias: Bullish

Goldiam's fresh ₹50 crore export order strengthens its pipeline and adds onto a robust ₹225 crore order book as of June 30, 2026, maintaining its strong growth trajectory and high earnings visibility.

Overweight: Consumer Discretionary, Gems & Jewellery

Trigger Factors:

• Timely execution of the ₹50 crore order by November 30, 2026.
• Sustaining higher operating margins, supported by the dual hybrid casting model in the US.
• Further expansion of the domestic 'ORIGEM' retail store footprint.

Time Horizon: Near-term (0-3 months)

Industry Context

The global gems and jewellery industry is undergoing a structural shift from natural diamonds to lab-grown diamonds. In India, exporters who have integrated vertically are leading this charge. Goldiam’s B2B export mix has seen LGD contribution rise steadily, hitting 90.7% in Q1 FY27 compared to 87.8% in Q1 FY26. Concurrently, the company is expanding its domestic retail footprint through its 'ORIGEM' brand, which reached 26 operational stores in August 2026, ensuring a diversified revenue base.

Key Risks to Watch

• Macroeconomic slowdown in the US market, which represents a highly concentrated share of overall export revenue.
• Intense price competition in lab-grown diamond manufacturing which could squeeze EBITDA margins.
• Volatility in USD-INR exchange rates affecting export realization values.

Recent Developments

In August 2026, Goldiam announced the opening of its 26th retail store under the B2C lab-grown diamond brand 'ORIGEM'. This followed an exceptional Q1 FY27 earnings release where total income rose 54.3% YoY to ₹363.66 crore, and net profit surged 120% YoY to ₹73.97 crore, helped by a one-time tariff refund of approximately ₹22 crore. Additionally, in July 2026, the company allotted bonus equity shares in a 1:3 ratio.

Closing Insight

Goldiam's securement of a ₹50 crore export order highlights the relentless momentum of the lab-grown diamond segment in the US. With a robust balance sheet featuring ₹456.67 crore in cash and investments and a debt-free status, the company is exceptionally positioned to execute its high-margin growth strategy both in export and domestic retail markets.

High Performance Trading with SAHI.